Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
Warning: file_get_contents(http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=18174448&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 445
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Novel therapeutic targets at the platelet vascular interface Brass LF; Zhu L; Stalker TJArterioscler Thromb Vasc Biol 2008[Mar]; 28 (3): s43-50Platelet activation in vivo can be part of the hemostatic response to injury or a pathological response to disease. In either setting, platelets adhere to the vessel wall and to each other, forming a closely packed mass interspersed with fibrin. Recent studies have identified new molecules on the platelet surface and within platelets that support and regulate thrombus growth and stability, ensuring that platelet accumulation after injury is sufficient to stop bleeding, but not so exuberant that vascular occlusion occurs. An understanding of how this balance is achieved helps to illuminate the events of platelet activation and, at the same time, provides potential targets for new classes of antiplatelet agents.|Animals[MESH]|Education, Medical, Continuing[MESH]|Endothelium, Vascular/drug effects/physiology[MESH]|Humans[MESH]|Integrins/drug effects/metabolism[MESH]|Platelet Activation/drug effects/physiology[MESH]|Platelet Aggregation Inhibitors/pharmacology/*therapeutic use[MESH]|Platelet Aggregation/*drug effects/physiology[MESH]|Sensitivity and Specificity[MESH]|Signal Transduction[MESH]|Thromboembolism/*prevention & control[MESH]|Vascular Cell Adhesion Molecule-1/*drug effects/metabolism[MESH] |
